[ Wed, Nov 15th 2023 ]: WOPRAI
[ Wed, Nov 15th 2023 ]: WOPRAI
[ Wed, Nov 15th 2023 ]: WOPRAI
[ Wed, Nov 15th 2023 ]: WOPRAI
[ Wed, Nov 15th 2023 ]: WOPRAI
[ Wed, Nov 15th 2023 ]: WOPRAI
[ Wed, Nov 15th 2023 ]: WOPRAI
[ Wed, Nov 15th 2023 ]: WOPRAI
[ Wed, Nov 15th 2023 ]: WOPRAI
[ Wed, Nov 15th 2023 ]: WOPRAI
[ Wed, Nov 15th 2023 ]: WOPRAI
[ Wed, Nov 15th 2023 ]: WOPRAI
[ Wed, Nov 15th 2023 ]: WOPRAI
[ Wed, Nov 15th 2023 ]: WOPRAI
[ Wed, Nov 15th 2023 ]: WOPRAI
[ Wed, Nov 15th 2023 ]: WOPRAI
[ Wed, Nov 15th 2023 ]: WOPRAI
[ Wed, Nov 15th 2023 ]: WOPRAI
[ Wed, Nov 15th 2023 ]: WOPRAI
[ Wed, Nov 15th 2023 ]: WOPRAI
[ Wed, Nov 15th 2023 ]: WOPRAI
[ Wed, Nov 15th 2023 ]: WOPRAI
[ Wed, Nov 15th 2023 ]: WOPRAI
[ Wed, Nov 15th 2023 ]: WOPRAI
[ Wed, Nov 15th 2023 ]: WOPRAI
[ Wed, Nov 15th 2023 ]: WOPRAI
[ Wed, Nov 15th 2023 ]: WOPRAI
[ Wed, Nov 15th 2023 ]: WOPRAI
[ Wed, Nov 15th 2023 ]: WOPRAI
[ Wed, Nov 15th 2023 ]: WOPRAI
[ Wed, Nov 15th 2023 ]: WOPRAI
[ Wed, Nov 15th 2023 ]: WOPRAI
[ Wed, Nov 15th 2023 ]: WOPRAI
[ Wed, Nov 15th 2023 ]: WOPRAI
[ Wed, Nov 15th 2023 ]: WOPRAI
[ Wed, Nov 15th 2023 ]: WOPRAI
[ Wed, Nov 15th 2023 ]: WOPRAI
[ Wed, Nov 15th 2023 ]: WOPRAI
[ Wed, Nov 15th 2023 ]: WOPRAI
[ Wed, Nov 15th 2023 ]: WOPRAI
[ Wed, Nov 15th 2023 ]: WOPRAI
[ Wed, Nov 15th 2023 ]: WOPRAI
[ Wed, Nov 15th 2023 ]: WOPRAI
[ Wed, Nov 15th 2023 ]: WOPRAI
[ Wed, Nov 15th 2023 ]: WOPRAI
[ Wed, Nov 15th 2023 ]: WOPRAI
[ Wed, Nov 15th 2023 ]: WOPRAI
[ Wed, Nov 15th 2023 ]: WOPRAI
Patrick Trucchio Reiterated (ALNY) at Strong Buy and Held Target at $395 on, Nov 15th, 2023
- 🞛 This publication is a summary or evaluation of another publication
Patrick Trucchio of HC Wainwright & Co., Reiterated "Alnylam Pharmaceuticals, Inc." (ALNY) at Strong Buy and Held Target at $395 on, Nov 15th, 2023.
Patrick has made no other calls on ALNY in the last 4 months.
There are 10 other peers that have a rating on ALNY. Out of the 10 peers that are also analyzing ALNY, 3 agree with Patrick's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Michael Ulz of "Morgan Stanley" Maintained at Hold with Increased Target to $183 on, Friday, November 3rd, 2023
- Olivia Brayer of "Cantor Fitzgerald" Maintained at Hold with Decreased Target to $170 on, Monday, October 16th, 2023
- Leland Gershell of "Oppenheimer" Downgraded from Buy to Hold on, Wednesday, October 11th, 2023
These are the ratings of the 7 analyists that currently disagree with Patrick
- Luca Issi of "RBC Capital" Maintained at Buy with Decreased Target to $230 on, Friday, November 3rd, 2023
- Kostas Biliouris of "BMO Capital" Maintained at Buy with Decreased Target to $234 on, Tuesday, October 10th, 2023
- David Lebovitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $233 on, Tuesday, October 10th, 2023
- Joseph Stringer of "Needham" Maintained at Strong Buy with Decreased Target to $200 on, Monday, October 9th, 2023
- Gary Nachman of "Raymond James" Initiated at Buy and Held Target at $208 on, Friday, September 29th, 2023
- Paul Matteis of "Stifel" Reiterated at Strong Buy and Held Target at $240 on, Thursday, September 14th, 2023
- Keay Nakae of "Chardan Capital" Reiterated at Strong Buy and Held Target at $250 on, Tuesday, August 8th, 2023